
TROV ), particularly within the context of its recent 8-K filing with the SEC. The filing, which states the terms of the collaboration between Trovagene and PerkinElmer ( PKI ) for the research and development of " Complete Story »
recently had its core technology validated by PerkinElmer ( PKI ). On April 25, 2013, Trovagene ..... Research and Development Agreement with PerkinElmer Health Sciences, Inc. (" PerkinElmer ") where TrovaGene will design an assay
By VFC : The imminent expectation of multiple product launches during the course of the coming year and the further development of a pipeline full of urine-based diagnostics designed to detect various cancers and infectious diseases placed Trovagene Inc (NASDAQ: TROV ) on the map during the closing
collaboration with the healthcare giant PerkinElmer Health Sciences ( PKI ). Outlined ..... the 8-K, is the agreement for PerkinElmer to design an assay to detect the ..... combining the TrNA Technology with PerkinElmer 's technology for the automation
ISI's Ross Muken downgrades PerkinElmer ( PKI -11.7% ) to Buy from Strong Buy after the company's Q1 miss . "This is a pretty terrible outcome from at least [an
By Tech Guru: PerkinElmer ( PKI )'s stock is down about 10% on Friday after missing consensus expectations for its 1Q earnings on both the top and bottom
PerkinElmer ( PKI ) Q1 2013 Earnings Call April 25, 2013 5:00 pm ET Executives ..... a href='http://seekingalpha.com/article/1374181- perkinelmer -management-discusses-q1-2013-results-earnings-call-transcript
April 25 (Reuters) - PerkinElmer Inc on Thursday reported lower-than-expected first-quarter profit and decreased its full-year forecast as difficult economic conditions and a stronger dollar hurt sales in Europe and Japan.
More on PerkinElmer 's ( PKI ) Q1 : Shares grind 14% lower in late trading after earnings miss on the top and bottom line. Adjusted operating profit
NEW YORK, April 25 (Reuters) - PerkinElmer Inc : * Shares were down 11.7 percent after the bell following results, outlook